[xoo_el_inline_form active="login"]

Armed-T, CytoArm
Banner1 2 Mb
Banner2 2
Banner2 2 Mb
Armed-T T cell
Banner3 2 Mb

BsAb Armed-T™ Therapy Platform

賽昂生醫開創T細胞癌症治療突破性發展

CytoArm’s innovative BsAb Armed-T therapy platform utilizes non-viral bi-functional antibodies (BsAb) to empower T cells in targeting tumor cells effectively. This pioneering approach enables adaptable cancer treatments across various oncological conditions, potentially addressing limitless diseases

CytoArm’s Non-Viral BsAb Armed-T therapy is a platform that Adaptable and Targeted Cancer Treatments covering over 50 diseases

Cytoarm Icon V4 工作區域 1
雙功能抗體 (BsAb) 透過與 T 細胞受體結合,活化免疫系統對腫瘤專一性攻擊
Cytoarm Icon V4 工作區域 1 複本
BsAb Armed-T™ cells provide promising adaptable cancer treatments
Cytoarm Icon V4 工作區域 1 複本 2
CytoArm can create BsAb Armed-T™ products to cover more than
50 diseases

賽昂最新動態

未命名設計 4

了解更多賽昂

Line 9

與賽昂聯繫

zh_TWChinese